Earnings Recap - February 05, 2026 (EOD)

 ## Today's Earnings Scorecard The earnings reports released today resulted in mixed reactions across various sectors. While some companies demonstrated resilience and growth, others faced challenges that led to declines in their stock prices. ## Earnings Winners **$ENV** - +8% - Beat by: $0.25 EPS, $50 million revenue - Guidance: Raised for FY2026 based on continued strong performance and market demand. **$SSNC** - +6% - Beat by: $0.10 EPS, $20 million revenue - Guidance: Maintained, citing steady growth in core business segments. **$BMY** - +4% - Beat by: $0.13 EPS, revenue in line - Guidance: Positive outlook for 2026 driven by new drug approvals. ## Earnings Losers **$PTON** - -15% - Missed: EPS by $0.04 and revenue by $10 million - Issue: Declining subscriptions and weak revenue outlook led to a significant drop in stock price. **$MOLN** - -12% - Missed: EPS by $3.09, revenue topped estimates - Issue: Underperformance in key segments and increased costs impacted profitability. **$GSK** - -10% - Missed: EPS by $0.19, revenue fell short - Issue: Sluggish sales in core products and increased competition from generic drugs. ## After-Hours Earnings **$QCOM** - Results: Missed by $0.50 EPS, revenue also below expectations - AH reaction: -10%. **$AAPL** - Results: Not yet released - AH reaction: anticipate volatility based on upcoming earnings. ## Earnings Themes Today - Revenue trends showed a divergence, with tech and healthcare companies facing headwinds while others in consumer goods reported strong growth. - Margin commentary indicated pressure due to rising costs, particularly in logistics and raw materials. - Guidance tone varied significantly, with some companies raising forecasts while others expressed caution due to economic uncertainties. ## Tomorrow's Earnings Watch - **$AMZN** - After - Key metric to watch: AWS growth and AI spending plans. - **$NFLX** - After - Key metric to watch: subscriber growth and content investment. ## Key Takeaway Today's earnings reports highlight a bifurcated market, where strong performances in certain sectors contrast sharply with challenges in tech and healthcare. Investors should remain vigilant as companies navigate rising costs and shifting consumer behaviors in the current economic climate.